A detailed history of Cornerstone Planning Group LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 8 shares of INVA stock, worth $178. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Previous 72 88.89%
Holding current value
$178
Previous $1.33 Million 89.16%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$18.17 - $20.92 $1,162 - $1,338
-64 Reduced 88.89%
8 $144,000
Q2 2025

Aug 11, 2025

BUY
$17.1 - $21.8 $1,231 - $1,569
72 New
72 $1.33 Million
Q4 2024

Jan 29, 2025

BUY
$17.35 - $20.32 $798 - $934
46 New
46 $873,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.55B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Cornerstone Planning Group LLC Portfolio

Follow Cornerstone Planning Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Planning Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Planning Group LLC with notifications on news.